Back to search

United Kingdom· GB-APID-20352211000001105

Co-codamol 30mg/500mg effervescent tablets

A medicinal product containing co-codamol, registered in United Kingdom by Advanz Pharma.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCo-codamol 30mg/500mg effervescent ta…ATC—REGISTER NO.GB-APID-2035221100000…PACKS LISTED2CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Co-codamol
Manufacturer
Advanz Pharma
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5060010017776
  • gtin
    5021691017776

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f983d2b8-ac94-4389-a7a3-b26ef45c55ab
GET /v1/drugs/f983d2b8-ac94-4389-a7a3-b26ef45c55ab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "20352211000001105",
  "desc": "Co-codamol 30mg/500mg effervescent tablets (Advanz Pharma)",
  "form": "Effervescent tablet",
  "vpid": "42009711000001109",
  "source": "dmd",
  "vtm_id": "44102411000001107",
  "strength": "30 mg",
  "substance": "Co-codamol",
  "ingredient": "Codeine phosphate",
  "supplier_code": "24129411000001106"
}

See everything about co-codamol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.